# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hereditary hemochromatosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-8 of 8 results.
A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis.
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Jun 29, 2017
Disease(s): Hereditary Hemochromatosis
Intervention(s): Deferasirox FCT, Phlebotomy
Locations: Lahey Hospital and Medical Center Center Primary, Burlington, Massachusetts, United States
Henry Ford Hospital, Detroit, Michigan, United States
Saint Louis University School of Medicine, Saint Louis, Missouri, United States
Lucas Research, Morehead City, North Carolina, United States
Novartis Investigative Site, Leuven, Belgium
... and 22 other locations.
PTG-300 in Subjects With Hereditary Hemochromatosis
Status: Recruiting
Last Changed: Dec 18, 2019
First Received: Dec 18, 2019
Disease(s): Hereditary Hemochromatosis
Intervention(s): PTG-300
Locations: Protagonist Investigational Site, Jacksonville, Florida, United States
Protagonist Investigational Site, Bethesda, Maryland, United States
Protagonist Investigational Site, Port Jefferson Station, New York, United States
Protagonist Investigational Site, Philadelphia, Pennsylvania, United States
Protagonist Investigational Site, Halifax, Nova Scotia, Canada
... and 1 other locations.
Treatment of Hemochromatosis
Status: Recruiting
Last Changed: Jan 06, 2020
First Received: Dec 11, 2000
Disease(s): Hemochromatosis
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Status: Recruiting
Last Changed: Jul 11, 2019
First Received: Mar 14, 2013
Disease(s): Hemochromatosis Type 1
Intervention(s): First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
Locations: CHU Pontchaillou, Rennes, France
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
Status: Not yet recruiting
Last Changed: Jul 18, 2019
First Received: Jun 18, 2019
Disease(s): Iron Metabolism Disorders, Iron Overload, Polyphenols
Intervention(s): meal matrix & NPPS, meal matrix & CS, no-matrix & NPPS, no-matrix & CS
Evaluation of Patients With Liver Disease
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: Jan 19, 2000
Disease(s): Biliary Liver Cirrhosis, Hemochromatosis, Hepatitis, Hepatolenticular Degeneration, Liver Disease
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
China Registry for Genetic / Metabolic Liver Diseases
Status: Recruiting
Last Changed: Apr 27, 2017
First Received: Apr 27, 2017
Disease(s): Genetic/Metabolic Liver Diseases
Intervention(s): Standard of care
Locations: Beijing Ditan Hospital, Beijing, Beijing, China
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Beijing YouAn Hospital, Beijing, Beijing, China
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
... and 8 other locations.
Liver Fibrosis in Sickle Cell Disease
Status: Recruiting
Last Changed: Nov 08, 2019
First Received: Dec 11, 2013
Disease(s): Sickle Cell Disease
Intervention(s): Liver transient elastography (Fibroscan), Ferriscan, Liver biopsy in iron overloaded subjects.
Locations: University of Miami, Miami, Florida, United States